PAUL A FRIEDMAN, a director at $MDGL, sold 2,110 shares of the company on 07-16-2025 for an estimated $744,133. We received data on the trade from a recent SEC filing. This was a sale of approximately 1.0% of their shares of this class of stock. Following this trade, they now own 203,318 shares of this class of $MDGL stock.
$MDGL Insider Trading Activity
$MDGL insiders have traded $MDGL stock on the open market 62 times in the past 6 months. Of those trades, 0 have been purchases and 62 have been sales.
Here’s a breakdown of recent trading of $MDGL stock by insiders over the last 6 months:
- REBECCA TAUB has made 0 purchases and 11 sales selling 31,438 shares for an estimated $10,957,123.
- PAUL A FRIEDMAN has made 0 purchases and 9 sales selling 28,876 shares for an estimated $10,198,844.
- ROBERT E. WALTERMIRE (Senior VP, Chief Pharma Dev.) has made 0 purchases and 13 sales selling 15,885 shares for an estimated $5,390,968.
- FRED B CRAVES has made 0 purchases and 13 sales selling 15,470 shares for an estimated $5,082,479.
- MARDI DIER (SVP and CFO) has made 0 purchases and 3 sales selling 2,219 shares for an estimated $720,592.
- CAROLE HUNTSMAN (Chief Commercial Officer) has made 0 purchases and 10 sales selling 2,181 shares for an estimated $714,167.
- WILLIAM JOHN SIBOLD (President and CEO) sold 1,584 shares for an estimated $531,020
- SHANNON T KELLEY (General Counsel) has made 0 purchases and 2 sales selling 692 shares for an estimated $214,759.
To track insider transactions, check out Quiver Quantitative's insider trading dashboard.
$MDGL Hedge Fund Activity
We have seen 162 institutional investors add shares of $MDGL stock to their portfolio, and 133 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- HOLOCENE ADVISORS, LP added 390,545 shares (+inf%) to their portfolio in Q1 2025, for an estimated $129,360,220
- FMR LLC removed 215,751 shares (-24.9%) from their portfolio in Q1 2025, for an estimated $71,463,203
- ADAGE CAPITAL PARTNERS GP, L.L.C. added 171,649 shares (+860.0%) to their portfolio in Q1 2025, for an estimated $56,855,298
- MORGAN STANLEY added 166,347 shares (+76.1%) to their portfolio in Q1 2025, for an estimated $55,099,116
- SUSQUEHANNA INTERNATIONAL GROUP, LLP added 126,320 shares (+773.9%) to their portfolio in Q1 2025, for an estimated $41,840,973
- SIREN, L.L.C. removed 125,942 shares (-100.0%) from their portfolio in Q1 2025, for an estimated $41,715,768
- HOOD RIVER CAPITAL MANAGEMENT LLC added 116,155 shares (+90.9%) to their portfolio in Q1 2025, for an estimated $38,474,020
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.
$MDGL Analyst Ratings
Wall Street analysts have issued reports on $MDGL in the last several months. We have seen 6 firms issue buy ratings on the stock, and 0 firms issue sell ratings.
Here are some recent analyst ratings:
- UBS issued a "Buy" rating on 05/02/2025
- B. Riley Securities issued a "Buy" rating on 05/02/2025
- Canaccord Genuity issued a "Buy" rating on 05/02/2025
- JMP Securities issued a "Market Outperform" rating on 04/24/2025
- Citigroup issued a "Buy" rating on 02/27/2025
- HC Wainwright & Co. issued a "Buy" rating on 02/27/2025
To track analyst ratings and price targets for $MDGL, check out Quiver Quantitative's $MDGL forecast page.
$MDGL Price Targets
Multiple analysts have issued price targets for $MDGL recently. We have seen 6 analysts offer price targets for $MDGL in the last 6 months, with a median target of $450.5.
Here are some recent targets:
- Eliana Merle from UBS set a target price of $458.0 on 05/02/2025
- Mayank Mamtani from B. Riley Securities set a target price of $460.0 on 05/02/2025
- Edward Nash from Canaccord Genuity set a target price of $420.0 on 05/02/2025
- Jonathan Wolleben from JMP Securities set a target price of $443.0 on 04/24/2025
- David Lebovitz from Citigroup set a target price of $469.0 on 02/27/2025
- Ed Arce from HC Wainwright & Co. set a target price of $405.0 on 02/27/2025
This article is not financial advice. See Quiver Quantitative's disclaimers for more information.
